Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

9
Number of overlapping holdings
33.3%
% of MEDX's 32 holdings also in PJP
37.5%
% of PJP's 24 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in PJP |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.7% | 6.7% | 6.7% | |
ABBVIE INC | 6.2% | 5.9% | 5.9% | |
AMGEN INC | 5.2% | 6.4% | 5.2% | |
JOHNSON & JOHNSON | 5.1% | 5.7% | 5.1% | |
PFIZER INC | 4.6% | 5.2% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
NOVARTIS AG-ADR | 5.5% | |
BRISTOL-MYERS SQUIBB CO | 5.1% | |
ELI LILLY & CO | 5.0% | |
ASTRAZENECA PLC-SPONS ADR | 4.7% | |
CRISPR THERAPEUTICS AG | 4.4% | |
IONIS PHARMACEUTICALS, INC. | 3.6% | |
SANOFI-AVENTIS-ADR | 3.4% | |
ALKERMES PLC | 3.3% | |
ALNYLAM PHARMACEUTICALS INC | 2.7% | |
EDITAS MEDICINE, INC. | 1.9% |
MEDX Underweight Relative to PJP
ABBOTT LABORATORIES | -6.1% | |
AMPHASTAR PHARMACEUTICALS INC | -3.9% | |
UNITED THERAPEUTICS CORP | -3.8% | |
TARO PHARMACEUTICAL INDUS | -3.8% | |
PRESTIGE BRANDS HOLDINGS INC | -3.7% | |
LIGAND PHARMACEUTICALS-CL B | -3.4% | |
JAZZ PHARMACEUTICALS PLC | -3.3% | |
SUPERNUS PHARMACEUTICALS INC | -3.2% | |
GERON CORP | -3.2% | |
VALEANT PHARMACEUTICALS INT'L | -3.1% |